Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 22 | $15,056,762 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
02 Dec 2022 17:48 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 30 Nov 2022 | Sale | 5,179 | 47.6044 | 246,543 | I |
02 Dec 2022 17:48 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 30 Nov 2022 | Sale | 6,851 | 46.4355 | 318,130 | I |
02 Dec 2022 17:48 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 30 Nov 2022 | Sale | 4,779 | 47.6044 | 227,501 | D |
02 Dec 2022 17:48 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 30 Nov 2022 | Sale | 6,322 | 46.4355 | 293,565 | D |
01 Nov 2022 17:38 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 28 Oct 2022 | Sale | 869 | 41.1204 | 35,734 | I |
01 Nov 2022 17:38 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 28 Oct 2022 | Sale | 22,096 | 40.279 | 890,005 | I |
01 Nov 2022 17:38 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 28 Oct 2022 | Sale | 800 | 41.1204 | 32,896 | D |
01 Nov 2022 17:38 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 28 Oct 2022 | Sale | 20,338 | 40.279 | 819,194 | D |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 27 Oct 2022 | Sale | 4,013 | 43.2321 | 173,490 | I |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 27 Oct 2022 | Sale | 23,719 | 42.0299 | 996,907 | I |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 27 Oct 2022 | Sale | 44,440 | 41.1156 | 1,827,177 | I |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 27 Oct 2022 | Sale | 3,693 | 43.2321 | 159,656 | D |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 27 Oct 2022 | Sale | 21,830 | 42.0299 | 917,513 | D |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 27 Oct 2022 | Sale | 40,903 | 41.1156 | 1,681,751 | D |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 26 Oct 2022 | Sale | 20,085 | 44.9002 | 901,821 | I |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 26 Oct 2022 | Sale | 12,537 | 43.9749 | 551,313 | I |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 26 Oct 2022 | Sale | 38,961 | 43.0756 | 1,678,268 | I |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 26 Oct 2022 | Sale | 18,486 | 44.9002 | 830,025 | D |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 26 Oct 2022 | Sale | 11,539 | 43.9749 | 507,426 | D |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 26 Oct 2022 | Sale | 35,860 | 43.0756 | 1,544,691 | D |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 25 Oct 2022 | Sale | 4,906 | 44.9163 | 220,359 | I |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 25 Oct 2022 | Sale | 4,515 | 44.9163 | 202,797 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)